BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

GC Pharma's plasma treatment allowed for actual use in treating COVID-19 patients

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : October 20, 2020, 15:33 | Updated : October 20, 2020, 15:33
  • 트위터
  • 페이스북
  • 웨이보

[Yonhap Photo]

SEOUL -- An immunoglobulin drug based on plasma containing antibodies won special approval to be used for the treatment of COVID-19 patients. The drug developed by GC Pharma, a biotech company in South Korea, has yet to complete clinical trials, but a state public health watchdog gave permission for critically ill patients who do not have other means of treatment.

The green light came from the Ministry of Food and Drug Safety, which allowed Kyungpook National University Hospital to administer GC5131A to patients hospitalized for COVID-19. GC Pharma has increased the production of GC5131A significantly for actual use in treating patients.

Plasma treatment is different from plasma therapy involving the infusion of blood plasma from COVID-19 survivors. GC5131A is still in a second-stage clinical study involving 60 people at six hospitals to set proper dosage and check safety and efficacy. Third-sage clinical trials will be carried out abroad.

South Korea has unveiled a roadmap for the treatment of COVID-19 to develop plasma treatment by the year's end as well as antibody treatment and vaccines next year. Second and third-stage clinical trials are under way to verify the efficacy and safety of Celltrion's COVID-19 antibody treatment, CT-P59. Celltrion has vowed to complete preparations for the mass supply of therapeutic antibodies for emergency domestic use by the end of this year.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .  Celltrion checks antibody treatments effect of COVID-19 infection prevention    .
    Celltrion checks antibody treatment's effect of COVID-19 i…
  • .Expert upholds masks as better than vaccines in preventing COVID-19 infection.
    Expert upholds masks as better than vaccines in preventing C…
  • .Celltrion makes preparations for emergency domestic use of COVID-19 antibodies.
    Celltrion makes preparations for emergency domestic use of C…
  • .GC Pharmas immunoglobulin drug administered to patients in second-stage clinical study .
    GC Pharma's immunoglobulin drug administered to patients in …
  • .S. Korea approves acquisition of COVID-19 vaccines for 60 % of entire population.
    S. Korea approves acquisition of COVID-19 vaccines for 60 % …

Real Time Photo News

  • .Singer HyunA to end 14-month hiatus with mini-album Im Not Cool.

    Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'

  • .NCSofts global K-pop fan community platform to service original content including songs.

    NCSoft's global K-pop fan community platform to service original content including songs

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

Latest News

more+

  • LA-bound Maersk containership loses some 750 containers overboard in Pacific
  • SK Bioscience selected to manage COVID-19 vaccine distribution in S. Korea
  • S. Korea finalizes official process of imposing 513% tariff on imported rice
  • Verizon becomes first to deploy Samsung's fully virtualized 5G solutions
  • Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view